Advertisement
Home Tags Eye / Vision Problems: Misc.

Tag: Eye / Vision Problems: Misc.

Xiidra (lifitegrast) eye drops have been approved by the U.S. Food and Drug Administration to treat symptoms of dry eye disease.

FDA Approves Xiidra Eye Drops to Treat Dry Eye Disease

0
First approved lymphocyte function-associated antigen agonist
Fungal keratitis patients pretreated with antifungal medication appear to have worse outcomes

No Response to First Antifungals Tied to Worse Keratitis Outcomes

0
Findings in fungal keratitis patients presenting for tertiary care after antifungal pretreatment
Severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy

Diabetic Retinopathy Independently Tied to Depression

0
Severe nonproliferative/proliferative diabetic retinopathy linked to greater depressive symptoms

June 2016 Briefing – Ophthalmology

0
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2016. This roundup includes the latest...
An implant that helps the aging eye focus on small print and nearby objects has been approved by the U.S. Food and Drug Administration.

FDA Approves Eye Implant to Correct Presbyopia in Middle Age

0
Tiny lens reshapes cornea to improve focus on small print, close objects
A short-lived optical sensation can lead some smartphone users to mistakenly believe they've lost sight in one eye

Smartphone Use at Night May Result in Monocular ‘Blindness’

0
Transient vision loss due to optical adaptation of the eyes caused by reading smartphone with one eye
In a letter published online June 22 in the New England Journal of Medicine

Zika Infection Also Linked to Uveitis in Adults

0
Physicians should note that a red eye associated with Zika is not necessarily only conjunctivitis
There is a need for development of new anti-herpetic compounds with different mechanisms of action for herpes simplex viral keratitis

Treatment Options Reviewed for Herpes Simplex Viral Keratitis

0
Options include acyclovir, valacyclovir, topical ganciclovir; need for development of new compounds
Intensive blood glucose control appears to reduce the risk of retinopathy progression in patients with type 2 diabetes

Intensive HbA1c Control Cuts Diabetic Retinopathy Progression

0
Patients with type 2 diabetes reduced their risk by half with intensive management
Compared with bevacizumab

Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab

0
Not cost-effective for diabetic macular edema unless prices decrease considerably